Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

ClinicalTrials.gov ID: NCT00035932

Public ClinicalTrials.gov record NCT00035932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 2:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Open Label Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn how well atazanavir (ATV) works in combination with ritonavir (RTV) or saquinavir (SQV) with tenofovir (TDF) and a nucleoside to reduce the viral load of treatment experienced subjects with human immunodeficiency virus (HIV). There is a comparison arm with lopinavir (LPV)/RTV and TDF and a nucleoside.

Study identification

NCT ID
NCT00035932
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
571 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2001 (Type not available)
Primary completion
Jul 2003 (Actual)
Completion
Mar 2009 (Actual)
Last update posted
Dec 24, 2010

2001 – 2009

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Not listed San Francisco California 94121 —
Not listed Torrance California 90502 —
Not listed Boulder Colorado 80304 —
Not listed Altamonte Springs Florida — —
Not listed Fort Lauderdale Florida 33306 —
Not listed Fort Lauderdale Florida 33308 —
Not listed Miami Beach Florida 33160 —
Not listed Orlando Florida 32801 —
Not listed Decatur Georgia — —
Not listed Honolulu Hawaii 96816 —
Not listed Boise Indiana — —
Not listed Wichita Kansas 67214 —
Not listed Louisville Kentucky 40202 —
Not listed New Orleans Louisiana — —
Not listed Brookline Massachusetts — —
Not listed Fall River Massachusetts 02720 —
Not listed East Orange New Jersey — —
Not listed Newark New Jersey 07103 —
Not listed Buffalo New York 14215 —
Not listed Manhasset New York 11030 —
Not listed New York New York 10019 —
Not listed Rochester New York 14620 —
Not listed Huntersville North Carolina 28078 —
Not listed Winston-Salem North Carolina 27157 —
Not listed Winston-Salem North Carolina 29203 —
Not listed Akron Ohio — —
Not listed Dallas Texas 75246 —
Not listed Dallas Texas — —
Not listed Houston Texas 77006 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00035932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 24, 2010 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00035932 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →